Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AML

NCT00430443 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

3

Enrollment

INDUSTRY

Sponsor class

Stopped Participants are no longer being examined or treated.

Conditions

Acute Lymphocytic Leukemia
Acute Myelogenous Leukemia

Interventions

DRUG: Liposomal Annamycin

Sponsor

Callisto Pharmaceuticals